Supporting
resilient
founders

Our goal is to be the first person the entrepreneur reaches out to in times of trouble and joy.

We are a sector agnostic early-stage investor that wants to partner with founders from the very beginning of their journey and support them throughout their growth. Our team has global experience in building and scaling companies both as founders and in various CxO roles. We invest in ambitious and determined teams that can one day become industry leaders.

Follow us on Twitter

New investments

Seed round

CurifyLabs

CEO: Charlotta Topelius
Founders: Charlotta Topelius, Niklas Sandler Topelius
Seed round

Hyperion Robotics

CEO: Fernando De los Rios
Founders: Fernando De los Rios, Ashish Mohite, Henry Unterreiner
Angel round

Focal

CEO: Tuomo Riekki
Founders: Tuomo Riekki, Andreas Stenman
Seed round

Droppe

CEO: Johannes Salmisaari
Founders: Johannes Salmisaari, Henrik Helenius
Series A

Mobal

CEO: Jakob Wikström
Founders: Jakob Wikström & Alexander Silén
Seed round

P2X Solutions

CEO: Herkko Plit
Founders: Herkko Plit, Jukka Juola
Seed round

Mjuk

CEO: Rickard Zilliacus
Founders: Rickard Zilliacus, Max Heino, Casper von Pfaler
Pre-seed round

Measurlabs

CEO: Teemu Myllymäki
Founders: Teemu Myllymäki, Kalle Lagerblom
Angel round

Flowrite

CEO: Aaro Isosaari
Founders: Aaro Isosaari, Karolus Sariola
Seed round

Spacent

CEO: Antti Tuomela
Founders: Antti Tuomela, Anssi Salonen, Eetu Ristaniemi, Jarmo Suominen

Portfolio events

Lifeline Ventures
Seed round

CurifyLabs

Through modernizing the drug compounding process in pharmacies, CurifyLabs enables sustainable, on-demand manufacture of medicines, customized to provide safe and effective treatment for all patients.

Read more

CurifyLabs

Through modernizing the drug compounding process in pharmacies, CurifyLabs enables sustainable, on-demand manufacture of medicines, customized to provide safe and effective treatment for all patients. CurifyLabs is committed to automating and streamlining the drug compounding process enabling personalization of drug treatments to better fit the need of each specific patient. Our goal is to maximize the personalization potential of drug treatments for better patient outcomes with our pharmaceutical 3D printing concept. The technology is based on over 10 years of extensive academic research conducted by Professor Niklas Sandler Topelius and his research group. Today CurifyLabs serves pharmacies on several European markets with a talented team of pharmaceutical formulation developers, software engineers and quality control experts.

CEO: Charlotta Topelius

Founders: Charlotta Topelius, Niklas Sandler Topelius

2021
Founded
2022
Lifeline Ventures
Seed round
6/2022
Seed round

Hyperion Robotics

Transforming the construction industry with large-scale 3D printing and low-carbon concrete.

Read more

Hyperion Robotics

Hyperion is transforming the way concrete structures are built with their 3D printing Micro-factories and low-carbon concrete made from industrial waste streams. The company works with industrial, infrastructure and building clients and helps them digitally design and robotically manufacture concrete structures without moulds with less materials and less cement, reducing project times, costs, health and safety risks and CO2 emissions.

CEO: Fernando De los Rios
Founders: Fernando De los Rios, Ashish Mohite, Henry Unterreiner

2019
Founded
2022
Lifeline Ventures
Seed round
6/2022
Series C
Led by Atomico

Aiven

Aiven has raised $100 million in its Series C, bringing the company’s total investment to $150 million. Aiven will use the proceeds from the round to bring new products to market, increase contributions to developing open source technologies and continue the company’s international expansion.

Read more

Aiven

Aiven provides fully managed cloud database and messaging services hosted in the cloud of the customer’s choice, including Amazon Web Services, Google Cloud Platform, and Microsoft Azure. Its mission is to allow developers to focus on building awesome applications without worrying about data infrastructure management.

CEO: Oskari Saarenmaa
Founders: Oskari Saarenmaa, Heikki Nousiainen, Mika Eloranta, Hannu Valtonen

2016
Founded
2017
Lifeline Ventures
Seed round
2019
Series A
Led by Earlybird
2020
Series B
Led by IVP
2021
Series C
Led by Atomico
05/2022
Series C
From Tesi, Lifeline Ventures, NordicNinja and Swisscanto

Varjo

Varjo, the leader in industrial-grade VR/XR hardware and software, has closed a $54 million round of Series C funding. The latest infusion of capital will allow Varjo to accelerate its global expansion and development of industry-leading hardware and software products.

Read more

Varjo

Varjo was founded by a team of industry professionals with decades of experience and a vision of seamlessly merging the virtual and real worlds. The Bionic Display™ in Varjo’s VR devices delivers an unprecedented human-eye resolution of 60 pixels per degree. It revolutionizes professional VR by bringing every detail, texture, contour and color into 20/20 focus.

CEO: Timo Toikkanen
Founders: Urho Konttori, Klaus Melakari, Roope Rainisto, Niko Eiden

2016
Founded
2016
Lifeline Ventures
Seed round
2017
Series A
Led by EQT Ventures
2018
Series B
Led by Atomico
2020
Series C
From Tesi, Lifeline Ventures, NordicNinja and Swisscanto
2022
Series D
From Tesi, Lifeline Ventures, Volvo Car Technology, Fefsi, Swisscanto and others
04/2022